FULC
Fulcrum Therapeutics, Inc. · Healthcare
Ra Capital Management, L.P. bought $1.3M of Fulcrum Therapeutics, Inc.
10% owner
Bought$1,314,806
$7.28Price
180,703Shares
+2%Stake
What FULC did for a copier
- $1,000 copied at Mon, Jan 9 open, $9.79
- $1,313
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Feb 22 close.
Ra Capital Management, L.P.'s record
63 other buys with 3 months of prices since 2016: on average +1.0% against the S&P 500, and 23 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jan 4. Filed Fri, Jan 6, 4:39 PM ET, after the close. Returns use the Jan 9 open and the Feb 22 close. Not investment advice.